FDA Consulting Services in Melbourne, Australia
Trusted by 1,000+ companies across 135+ countries, with 15+ years of FDA regulatory experience. As a U.S.-based firm, we help Melbourne pharma, biologics, biotech, supplement, skincare, and food exporters register with the FDA and reach the U.S. market, and we can serve as your U.S. Agent where FDA requires one.
Confirm which FDA programs apply before your first U.S. shipment or submission. Tell us what your Melbourne company makes, whether it is a finished drug, an active ingredient, a biologic, or a consumer product, and who will import it. We can identify the registrations, listings, U.S. Agent, labeling, DMF, and application questions to address, handled remotely from the United States.
Request My Melbourne FDA AssessmentFDA Services for Melbourne Exporters
Drugs & Biologics
Pharma, vaccines, plasma & biotech. Drug establishment registration, listing, NDC, DMF, CGMP, NDA/ANDA/BLA pathways & U.S. Agent.
Medical Devices
Device and diagnostic exporters. Foreign device establishment registration, listing, 510(k)/De Novo/PMA pathway, QMSR, and a U.S. Agent.
Supplements & Cosmetics
Complementary medicines & skincare. Supplement facility registration with Part 111 CGMP and a U.S. Agent; MoCRA cosmetic registration, with a U.S. Agent for the foreign facility.
Food & Beverage
Dairy, food & nutraceuticals. Foreign food facility registration, label & safety review, U.S. Agent, FSVP & Prior Notice.
Listed, Approved, or Licensed?
For a drug or biologic, registering is not the same as being allowed to sell. Registration and listing identify you to the FDA; a separate application — set by the product type — decides market access.
| Product | What it is | FDA pathway |
|---|---|---|
| OTC monograph drug | Non-prescription | Register & list; follow the monograph |
| New prescription drug | Novel medicine | NDA (premarket approval) |
| Generic drug | Equivalent to an approved drug | ANDA (approval via equivalence) |
| Biologic | Vaccine, plasma-derived product, antivenom, cell or gene therapy | BLA (biologics license, CBER) |
Calling a medicine “FDA approved” when it is only registered is misleading and can misbrand the product. We confirm your establishment registration and listing, obtain your NDC labeler code, align your CGMP documentation, prepare any Drug Master File, and map the right application — NDA, ANDA, or BLA — so your drug or biologic reaches the U.S. the right way.
A Biomedical Capital, Cleared for the U.S.
Melbourne is Australia's biomedical capital. It accounts for about 60% of Australia's pharmaceutical exports, and the Parkville precinct brings together more than 40 hospitals, medical research institutes, biotechnology organisations, and universities (Invest Victoria). CSL began there in 1916 as Commonwealth Serum Laboratories and now has its global headquarters in Parkville (CSL), part of a long history of vaccine, plasma, and antivenom manufacturing. The city also exports complementary medicines, cosmetics, medical devices, and foods.
For the U.S. market, each category has its own track. Drugs register and list with an NDC code, meet CGMP, and clear an NDA or ANDA; biologics like vaccines and plasma-derived products are licensed through a BLA via the FDA's biologics center, CBER. Devices register and list with a premarket pathway; supplements register as food facilities and follow Part 111 CGMP; cosmetics follow MoCRA; and food needs foreign facility registration, FSVP, and Prior Notice. Wine needs both FDA food facility registration and Prior Notice and label approval from the Alcohol and Tobacco Tax and Trade Bureau. We're a U.S.-based firm guiding Melbourne exporters across every FDA-regulated category; for country-level guidance, see FDA registration services in Australia.
FDA Planning Points for Melbourne Pharma and Biologics Exporters
Most Melbourne projects start with the same three questions: what carries over from the TGA, what the FDA fees are, and what a DMF and U.S. labeling involve.
TGA Approval Does Not Transfer
FDA's mutual recognition agreements for drug inspections cover the EU, Switzerland, and the UK, not Australia (FDA), so ARTG registration and a TGA GMP licence do not replace FDA approval or inspection. One exception for cancer medicines: Project Orbis lets FDA and the TGA review oncology applications at the same time (FDA).
FY 2027 Drug User Fees
Registering a drug establishment has no fee, but applications and some facilities do. An NDA or BLA with clinical data costs $4,600,753, and a small business may qualify for a waiver on its first application (FDA). For generics, an ANDA is $375,684 and a foreign API facility pays $54,680 a year (Federal Register). An OTC monograph facility pays $47,891 (FDA).
DMFs and U.S. Drug Labeling
A Drug Master File is not required by statute or regulation; FDA reviews it only when an NDA, ANDA, IND, or BLA references it (FDA). A Type II API DMF pays a one-time $109,899 fee when first referenced in a generic application (FDA). Prescription labels follow the PLR format in 21 CFR 201.56 and 201.57 (FDA), and OTC labels use Drug Facts.
Other Australia service areas: Sydney, Brisbane, and Fremantle.
A Step-by-Step Checklist
FDA Registration for Every Product Type
Whatever you export from Melbourne, we handle the full FDA pathway by category: FDA drug establishment registration, drug labeling, medical device registration, dietary supplement registration, MoCRA cosmetic registration, and FDA food facility registration — with U.S. Agent services where FDA requires them. Tell us your product and pathway, and we'll map the exact steps.
FDA Compliance for Your Melbourne Exports
Tell us your product and company — drugs, active ingredients, biologics, vaccines, supplements, cosmetics, or food — and we'll confirm which FDA registrations, listings, and approval pathways apply, review your labeling, prepare any Drug Master File, serve as your U.S. Agent where one is required, and coordinate FSVP and Prior Notice for any food.
- Identify which FDA programs apply to each product and manufacturing site.
- Confirm NDC, DMF, labeling, U.S. Agent, and importer responsibilities.
- Agree the scope, required documents, and pricing before any paid work begins.
Contact our specialists, email info@fdaregistrationassistance.com, or call +1 (928) 275-8333. Drug establishment registration · Registration pricing · All service areas.
Request My Melbourne FDA AssessmentFDA Registration Assistance is a private consulting firm, not FDA or the TGA. Professional assistance is not government approval or a guarantee of a regulatory outcome.
Frequently Asked Questions — FDA Consulting in Melbourne, Australia
Do companies in Melbourne need FDA registration to sell in the U.S.?
Many do. If your Melbourne business makes FDA-regulated drugs, biologics, foods, supplements, or cosmetics intended for the U.S. market, the foreign establishment generally must register with the FDA. Drugs and biologics register and list; what you file depends on the product.
What makes Melbourne distinctive for FDA compliance?
Melbourne is Australia's biomedical capital, with a deep base in pharmaceuticals, vaccines, plasma products, and biotech. So the FDA work here often centers on drugs and biologics — establishment registration, the right approval pathway, and a U.S. Agent — alongside food, supplements, and cosmetics.
Do Australian pharmaceutical makers have to register with the FDA?
Yes. A foreign drug establishment that makes, repacks, or relabels drugs for the U.S. registers with the FDA, lists its products, and appoints a U.S. Agent. There is no FDA fee to register, and registration renews annually between October 1 and December 31. We handle the registration, listing, and agent appointment.
What is an NDC labeler code?
The National Drug Code is a three-segment number: the labeler code identifies your firm, and the product and package codes identify each drug. A labeler code is requested from FDA before listing, each product is then listed electronically in SPL format, and the NDC is normally printed on the label. We obtain the code and set up your listings.
What is a Drug Master File?
A Drug Master File, or DMF, is a confidential submission with detailed information about facilities, processes, or materials used in making a drug, most often an active ingredient. It is voluntary, but it lets an Australian supplier support a customer's NDA, ANDA, or BLA without sharing its process (FDA). Type II API DMFs used for generics pay a one-time GDUFA fee. We prepare and submit it.
What is CGMP, and does it apply to us?
Current Good Manufacturing Practice is the FDA's manufacturing-quality standard for drugs, set out in 21 CFR Parts 210 and 211, with ICH Q7 as the standard for active ingredients. Foreign drug facilities must meet it and can be inspected by the FDA; a TGA GMP licence does not replace an FDA inspection. We help you confirm your quality system and documentation meet the FDA's expectations.
Is registration the same as FDA approval?
No, and this matters most for drugs and biologics. Registration and listing tell the FDA you exist and what you make. A new drug still needs an approved application — an NDA, or for generics an ANDA — before it can be marketed. We map both.
How are vaccines, plasma, and antivenoms handled?
Those are biologics, licensed through a Biologics License Application. FDA's biologics center, CBER, regulates vaccines, blood and blood components, plasma-derived products, and gene and cellular therapies (FDA), and antivenoms are also biologics. Melbourne's strength in vaccines and plasma makes this central, and we map the pathway.
What is the difference between an NDA, an ANDA, and a BLA?
An NDA approves a new drug, an ANDA approves a generic by showing equivalence, and a BLA licenses a biologic such as a vaccine. The right one depends on your product. We help you identify and prepare the correct application.
Do over-the-counter drugs follow a different path?
Often, yes. Many OTC drugs are marketed under an FDA monograph rather than an individual approval, but the facility still registers, lists, follows CGMP and Drug Facts labeling rules, and pays the annual OMUFA facility fee, $47,891 for FY 2027. Sunscreens are OTC drugs in the U.S. We confirm whether your product fits a monograph.
We work in biotech, cell, or gene therapy — does the FDA regulate that?
Yes. Cell and gene therapies and many advanced biologics are regulated by the FDA's biologics center, with rigorous requirements. Melbourne's research base makes this common, and we map the registration and pathway.
What about combination products, like a prefilled syringe or drug-device kit?
Combination products are assigned to a lead FDA center based on their primary mode of action, and they can involve both drug and device requirements, including CGMP for drugs and the device QMSR. We help you determine the lead center and map the combined obligations.
Is a U.S. Agent required for an Australian company?
Yes, in every FDA program that registers foreign facilities. Foreign drug, device, food and cosmetic establishments must designate a U.S. Agent located in the United States, who serves as FDA's contact for communications, inspection scheduling, and emergencies. Foreign cosmetic facilities registering under MoCRA must name one too. FDA Registration Assistance can act as your U.S. Agent.
Australia has a big vitamins and supplements industry — how are those handled?
AUST L complementary medicines (TGA) and nutraceuticals are usually dietary supplements in the U.S., a category of food. There is no FDA product registration; the facility registers as a food facility, appoints a U.S. Agent, follows the CGMP rule in 21 CFR Part 111, and uses a Supplement Facts label, and TGA indications often need rewording because disease claims are not allowed. We set it up.
Do cosmetic and personal-care exporters register?
Generally yes. Under MoCRA, the foreign cosmetic manufacturer registers its facility, and the Responsible Person, the manufacturer, packer, or distributor named on the label, lists each product and substantiates safety. Small businesses may be exempt from some requirements, and a foreign facility must name a U.S. Agent when it registers. Products with an SPF claim are OTC drugs, not cosmetics.
Do medical device exporters from Melbourne register?
Yes. Foreign device establishments register and list with the FDA, pay the annual establishment fee ($13,785 for FY 2027), appoint a U.S. Agent, follow the Quality Management System Regulation, which took effect February 2, 2026 (FDA), and use the right premarket pathway. We map the requirements for any Melbourne device or diagnostic maker.
Do food and beverage exporters register?
Yes. Foreign food facilities, including Victoria's dairy and food producers, register and appoint a U.S. Agent, the U.S. importer generally runs FSVP, and Prior Notice is filed before each shipment. We map labeling and safety requirements for each product.
Is Australian wine FDA-regulated?
Partly. Wineries are food facilities, so they register with FDA and each shipment needs Prior Notice (TTB). Label approval, the COLA, and alcohol permits come from the Alcohol and Tobacco Tax and Trade Bureau (TTB), and alcohol importers can be exempt from FSVP. See our wine and spirits import guide.
What is FSVP, and who is responsible for it?
For food, the Foreign Supplier Verification Program is generally the U.S. importer's responsibility — they verify the foreign supplier meets U.S. safety standards. Because FDA recognizes Australia's food safety system as comparable, importers can use modified requirements for some foods, though supplements, Grade A dairy, and alcohol are excluded (FDA). It doesn't apply to drugs, biologics, or devices. We support your food registration and the importer's FSVP.
Do drug and biologic labels need to meet U.S. rules?
Yes. Prescription drugs and biologics use the Physician Labeling Rule format, with Highlights, Full Prescribing Information, and a table of contents, while OTC drugs use the Drug Facts panel; labeling is also submitted to FDA in SPL format. We provide drug labeling services and review labeling and packaging so products aren't misbranded or held at entry.
What happens if a product doesn't comply at the U.S. border?
The FDA can refuse admission, detain shipments, issue warning letters, or place products on import alert. For drugs and biologics, marketing without an approved or licensed application is a serious violation. A review before you ship is essential.
Does FDA registration mean our product is FDA approved?
No. Registration and listing are mandatory steps, not approval. A drug or biologic still needs an approved or licensed application to be marketed. Claiming “FDA approved” when you are only registered is misleading and can misbrand the product.
Is FDA registration the same as meeting customs and trade rules?
No. FDA registration is separate from, and in addition to, U.S. customs, import, and other applicable trade laws. We handle the FDA side; your importer and customs broker handle entry and any other requirements.
How often do registrations renew?
Drug and device establishment registrations renew annually, between October 1 and December 31, and drug listings are certified each year. Foreign food facility registrations renew every two years in the same window of even-numbered years, so the current window runs to December 31, 2026. Cosmetic facility registrations renew every two years, and MoCRA product listings are updated annually. A DUNS Number is required for drug establishments and food facilities. We track and manage every renewal so nothing lapses.
How do I get started?
Send us your product and company details — drugs, biologics, vaccines, supplements, cosmetics, or food — using the form at the bottom of this page, or contact our team, and we'll confirm which FDA registrations, listings, and approval pathways apply to your Melbourne business, review your labeling, and handle the registration, U.S. Agent appointment, and filings. Email info@fdaregistrationassistance.com or call +1 (928) 275-8333.
Request FDA Support for Your Melbourne Business
Tell us what your company makes, sells, or distributes, where each product is manufactured or packed, your U.S. importer or buyer arrangement, label readiness, and target shipment date.
Submitting this inquiry does not purchase a service or authorize paid work. Our team can discuss the scope and required materials before you commission assistance. Fields marked with an asterisk are required.